Table 4.
Kaplan-Meier Survival analysis
| Gastric Adenocarcinoma (n=193) | ||||
|---|---|---|---|---|
| No | Mean time to survival (months) (95% CI) |
p value | ||
| Age | <60 ≥60 |
118 75 |
39.6 (37.943-41.235) 37.2 (34.799-39.581) |
0.606 |
| Gender | male female |
123 70 |
38.8 (36.995-40.648) 39.5 (37.347-41.619) |
0.612 |
| Differentiation | differentiated less-differentiated |
108 85 |
38.8 (36.797-40.747) 39.4 (37.457-41.335) |
0.582 |
| Lauren classification | intestinal diffuse |
130 63 |
39.3 (37.584-40.980) 38.7 (36.181-41.114) |
0.714 |
| pT | T1 T2-T4 |
81 112 |
41.6 (40.448-42.757) 37.2 (35.007-39.394) |
0.002* |
| pN | N0 N1-3 |
107 86 |
42.2 (41.419-42.957) 35.0 (32.284-37.802) |
0.000* |
| Stage | I II III |
91 42 60 |
40.9 (40.015-41.749) 41.8 (40.145-43.529) 31.4 (28.063-34.835) |
0.000* |
| HIF-1α | negative positive |
92 101 |
40.3 (38.614-41.911) 37.9 (35.741-40.104) |
0.283 |
| GLUT-1 | negative positive |
110 83 |
40.2 (38.639-41.674) 37.5 (35.005-40.016) |
0.042* |
| CA-9 | negative positive |
83 110 |
39.0 (36.841-41.089) 39.1 (37.201-40.905) |
0.705 |
| iNOS | negative positive |
110 83 |
39.4 (37.614-41.212) 38.6 (36.360-40.772) |
0.682 |
* statistically significant